This hub offers a wide array of tools, publications, and other media to assist researchers working in contraception and prevention of HIV and other STIs in keeping end-users in mind from the beginning and throughout the product development life cycle.

Why a socio-behavioral research hub for the MPT field?

  • There are many complexities in developing MPTs that will be safe, effective, affordable, and used by women.
  • One key aspect of this process is to study the desirability and acceptability of an MPT candidate during its development so that, when it reaches the market, women will actually use it.
  • It is essential for multidisciplinary experts—including those with expertise in HIV, other STIs, contraception, socio-behavioral and market research, drug development, and clinical research—to connect and collaborate to facilitate integration of end-user research throughout different phases of product development.

Browse our featured categories to find the right resources to support your work!

Journal Articles

  • HIV prevention: better choice for better coverage (2022)
  • Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention (2021)
  • Giving Voice to the End-User: Input on Multipurpose Prevention Technologies From the Perspectives of Young Women in Kenya and South Africa (2021)
  • Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake (2021)
  • Microarray patches: Breaking down the barriers to contraceptive care and HIV prevention for women across the globe (2021)
  • HIV prevention is not all about HIV – using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection (2020)
  • Insights for Implementation Science From 2 Multiphased Studies With End-Users of Potential Multipurpose Prevention Technology and HIV Prevention Products (2019)
  • “We are not the same”: African women’s view of multipurpose prevention products in the TRIO clinical study (2019)
  • Young women’s stated preferences for biomedical HIV prevention results of a discrete choice experiment in Kenya and South Africa (2019)
  • A strategic action framework for multipurpose prevention technologies combining contraceptive hormones and antiretroviral drugs to prevent pregnancy and HIV (2018)
  • Dual HIV and pregnancy prevention cost effective? (2018)
  • Effectiveness of female condom in preventing HIV and sexually transmitted infections: a systematic review protocol (2018)
  • The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention (2018)
  • Young Women’s Ratings of Three Placebo Multipurpose Prevention Technologies for HIV and Pregnancy Prevention in a Randomized, Cross-Over Study in Kenya and South Africa (2018)
  • The cost-effectiveness of multi-purpose HIV and pregnancy prevention technologies in South Africa (2018)
  • End-users’ product preference across three multipurpose prevention technology delivery forms: Baseline results from young women in Kenya and South Africa (2018)
  • Vaginal Film for Prevention of HIV: Using Visual and Tactile Evaluations among Potential Users to Inform Product Design (2017)
  • The promise of multipurpose pregnancy, STI, and HIV prevention (2017)
  • Indigenous HIV Prevention Beliefs and Practices Among Low-Earning Chinese Sex Workers as Context for Introducing Female Condoms and Other Novel Prevention Options (2016)
  • Qualitative Analysis of Sexually Experienced Female Adolescents: Attitudes about Vaginal Health (2016)
  • Knowledge, attitudes, practices, and behaviors associated with female condoms in developing countries: a scoping review (2016)
  • How to sell a condom? The impact of demand creation tools on male and female condom sales in resource limited settings (2016)
  • Preferences for ARV-based HIV prevention methods among men and women, adolescent girls and female sex workers in Gauteng Province, South Africa: a protocol for a discrete choice experiment (2016)
  • Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study (2016)
  • Nonuse of contraception among women at risk of unintended pregnancy in the United States (2015)
  • The FACTS about women and pre-exposure prophylaxis (2015)
  • Acceptability and preferences for vaginal dosage forms intended for prevention of HIV or HIV and pregnancy (2015)
  • Engaging male partners in women’s microbicide use: evidence from clinical trials and implications for future research and microbicide introduction (2014)
  • An interdisciplinary framework for measuring and supporting adherence in HIV prevention trials of ARV-based vaginal rings (2014)
  • Qualitative research from the VOICE trial reveals women’s challenges in adherence (2014)
  • Contraception and prevention of HIV transmission: a potential conflict of public health principles (2014)
  • Efficacy of behavioral interventions to increase condom use and reduce sexually transmitted infections: a meta-analysis, 1991 to 2010 (2011)
  • Baseline correlates of inconsistent and incorrect condom use among sexually active women in the Contraceptive CHOICE Project (2011)

    • Tools

  • Word on the Street: African Women Share Their Reproductive Health Stories (2022)
  • TRIO Study Brief: Long-Acting Injections for Women’s HIV Prevention in Sub-Saharan Africa: What End-Users Think (2021)
  • Toward a Roadmap for Biomedical HIV Prevention Investment Standards: Strategic Insights from Key Industry Stakeholders (2019)
  • Market Access Framework for Multipurpose Prevention Technology (MPT) Development and Introduction (2019)
  • MPT Target Population Identification Mapping Tool (2019)
  • Traditional Socio-Behavioral Research and Human-Centered Design: Similarities, Unique Contributions and Synergies (2017)
  • Building MPT acceptability during product development through consumer and health systems research (2017)
  • MPTs: Building momentum through awareness-raising and advocacy (2017)
  • Multipurpose Prevention Technologies (MPTs): Innovation to Protect Women’s Reproductive Health in Kenya (2014)
  • Global Reproductive Health Diaries (2013)

    • Reports

  • A Thought Paper on Fostering Greater Utilization of Social and Behavioural Research in The Development Setting and Creating Impact (2022)
  • Multipurpose Prevention Technologies: Technology Landscape and Potential for Low- and Middle-Income Countries (2021)
  • Dual Prevention Pill: A Summary of Insights and Recommendations on the uptake of the combined PrEP and Oral Contraceptive pill by women of reproductive age in South Africa and Zimbabwe (2021)
  • Recommendations and Solutions from Human-Centered Design Research on the Dual Prevention Pill (2021)
  • Microbicide Trials Network (MTN) Socio-behavioral Research Compendium (2021)
  • Exploring intravaginal ring acceptability for disease prevention among at-risk community members in Cape Town (2017)
  • HIV Prevention Products – Dapivirine Ring & Oral Truvada (2017)
  • Understanding consumer preference for HIV prevention products: Quantitative findings from surveys with 18-21 year old young women in South Africa (2017)
  • Understanding consumer preference for HIV prevention products: Qualitative findings from discussions with 18-21 year old young women in South Africa (2017)
  • The importance of sexual and reproductive health and rights to prevent HIV in adolescent girls and young women in eastern and southern Africa (2017)
  • MPTs – Strategy, Research & Product Development (2016)
  • Assessing the Potential of MPTs in South Africa, Uganda and Nigeria (2014)
  • Meeting Report: International Symposium on Accelerating Research on Multipurpose Prevention Technologies for Reproductive Health (2013)
  • Developing a Strategy for Female Condom Parallel Programming (2011)
  • Female Condoms and U.S. Foreign Assistance: An Unfinished Imperative for Women’s Health (2011)

    • Webinars

  • Demand for Novel Male Contraceptives & Requisite Need for Development of Male MPTs in Select LMICs (2023)
  • Considerations when Transitioning an MPT Product Candidate from Preclinical to Clinical Development (2022)
  • Integrating End-User Research in MPT Product Development & Commercialization Strategies (2022)
  • Integrating Socio-behavioral & Market Research into MPT R&D: Applying Lessons Learned (2021)
  • MPT End-User Research: Updates from the Field (2017)

    • Presentations

  • Exploring the R&D Landscape and Potential of Multipurpose Prevention Technologies (2022)
  • Market Assessment Needs for MPTs – The Human Factor: Applications for Product Development & Early Stage Clinical Trials (2016)
  • Multipurpose Prevention Technologies (2014)
  • Round Table Discussion: Multipurpose Prevention Technologies (2014)
  • Indian women’s perceptions of vaginal rings-feedback for development of multipurpose prevention technologies (2013)
  • Introducing Novel Technologies at the Country Level; Promoting Approval, Access and Acceptance (2013)
  • MPTs: Assessing Acceptability and Adherence (2013)
  • The Reality on the Ground: What Users and Providers Want and Need in MPTs (2013)
  • What do these technologies mean for women living with HIV? (2013)
  • What Have We Learned From Other Reproductive Health Technologies? (2012)
  • Users’ and Providers’ Perspectives on MPTs: What do we know, and what do we need to know? (2012)
  • Involving End Users and Health System in the Development of/Access to MPTs: The Indian context (2012)
  • Availability, Access and Utilization of MPTs: Issues and Challenges (2012)

    • Media

  • Sexual Satisfaction Results With the Vaginal pH Modulator From the Phase 3 AMPOWER Study (2022)
  • Watch: Now a rap song to promote use of condoms (2019)
  • ‘Female condom’ gets a genderless rebrand from FDA (2019)
  • African women prefer multipurpose HIV prevention products (2019)
  • Maximise benefits of female condom, physician counsels women (2019)
  • Survey reveals high number of sexually active women who use no birth control method, supporting the continued need for non-hormonal birth control innovations such as Evofem Biosciences’ Amphora (2018)
  • Celebrating #NextGenContraception on World Contraception Day (2018)
  • ‘Now, few takers for ‘government condoms’ as users look for other options’ (2018)
  • Women around the world lack access to comprehensive contraception-this is the solution (2018)
  • Contraceptive technology innovation: It’s everyone’s business (2018)
  • Getting behind human-centered design for contraceptive innovation (2018)
  • 3D printed intravaginal rings to help protect women from HIV infection and unintended pregnancy (2018)
  • This week in sex: Does game-changing HIV prevention regimen reduce condom use? (2018)
  • Human-centered design and socio-behavioral research: scientific rigor with a dash of savvy and spice (2018)
  • World Contraception Day: Body calls on stakeholders to make access to modern contraception easy (2018)
  • Empowerment – the payoff of new HIV prevention tools for young women (2017)
  • CONRAD launches Quatro in South Africa and Zimbabwe (2016)
  • Competing Priorities: Partner-Specific Relationship Characteristics and Motives for Condom Use Among At-Risk Young Adults (2016)
  • Biomarkers and biometric measures of adherence to use of ARV-based vaginal rings (2016)
  • This Week in Sex: News From the HIV Epidemic (2016)
  • 3 Bodies sensitise women to female condom (2015)
  • H.I.V. Drugs: A Failed Trial [Letter to the editor] (2015)
  • Does New HIV-Prevention Technology Empower or Burden Women? (2014)
  • Can you imagine a world without condoms for safe sex? Scientists can (2014)
  • MPTs as Seen From a Bowl of Salad Combo (2014)
  • As strategies to prevent HIV and unintended pregnancies evolve, concepts of “multi-purpose technologies” raise a familiar question (2014)
  • So When Will the Next Big Thing Be Available for General Use? (2014)
  • The South African HIV scientist who gave girls back control of their bodies (2014)
  • Improving SRH and HIV Integration is key for delivering new multipurpose prevention technologies. (2014)
  • NIH’S Dr. Gina Brown reflects on HIV among women and girls – Highlights from AIDS 2014 (2014)

    • Please contact us if you have a resource that you would like included here or if you would like more support in finding exactly what you are looking for.